Literature DB >> 16990828

Narcolepsy and the hypocretin system--where motion meets emotion.

Jerome M Siegel1, Lisa N Boehmer.   

Abstract

Narcolepsy is a neurological disorder that is characterized by excessive daytime sleepiness and cataplexy--a loss of muscle tone generally triggered by certain strong emotions with sudden onset. The underlying cause of most cases of human narcolepsy is a loss of neurons that produce hypocretin (Hcrt, also known as orexin). These cells normally serve to drive and synchronize the activity of monoaminergic and cholinergic cells. Sleepiness results from the reduced activity of monoaminergic, cholinergic and other cells that are normally activated by Hcrt neurons, as well as from the loss of Hcrt itself. Cataplexy is caused by an episodic loss of activity in noradrenergic cells that support muscle tone, and a linked activation of a medial medullary cell population that suppresses muscle tone. Current treatments for narcolepsy include stimulants to combat sleepiness and antidepressants to reduce cataplexy. Sodium oxybate produces both reductions in cataplexy and improved waking alertness. Future treatments are likely to include Hcrt or Hcrt agonists to reverse the underlying neurochemical deficit.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16990828      PMCID: PMC8766427          DOI: 10.1038/ncpneuro0300

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  51 in total

Review 1.  Orexins in the brain-gut axis.

Authors:  Annette L Kirchgessner
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

2.  Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2.

Authors:  Diane L Rosin; Matthew C Weston; Charles P Sevigny; Ruth L Stornetta; Patrice G Guyenet
Journal:  J Comp Neurol       Date:  2003-10-27       Impact factor: 3.215

3.  Neurons containing hypocretin (orexin) project to multiple neuronal systems.

Authors:  C Peyron; D K Tighe; A N van den Pol; L de Lecea; H C Heller; J G Sutcliffe; T S Kilduff
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

4.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

5.  Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats.

Authors:  Joshi John; Ming-Fung Wu; Tohru Kodama; Jerome M Siegel
Journal:  J Physiol       Date:  2003-03-07       Impact factor: 5.182

6.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

7.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

Authors:  L de Lecea; T S Kilduff; C Peyron; X Gao; P E Foye; P E Danielson; C Fukuhara; E L Battenberg; V T Gautvik; F S Bartlett; W N Frankel; A N van den Pol; F E Bloom; K M Gautvik; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

8.  Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.

Authors:  Michihiro Mieda; Jon T Willie; Junko Hara; Christopher M Sinton; Takeshi Sakurai; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-16       Impact factor: 11.205

9.  Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.

Authors:  A M Blouin; T C Thannickal; P F Worley; J M Baraban; I M Reti; J M Siegel
Journal:  Neurology       Date:  2005-08-31       Impact factor: 9.910

10.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

View more
  28 in total

Review 1.  [Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 2.  K+ channels stimulated by glucose: a new energy-sensing pathway.

Authors:  Denis Burdakov
Journal:  Pflugers Arch       Date:  2007-01-06       Impact factor: 3.657

3.  Orexin/hypocretin receptor signalling: a functional perspective.

Authors:  C S Leonard; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 4.  Waking with the hypothalamus.

Authors:  Helmut L Haas; Jian-Sheng Lin
Journal:  Pflugers Arch       Date:  2011-07-28       Impact factor: 3.657

5.  White and gray matter abnormalities in narcolepsy with cataplexy.

Authors:  Christoph Scherfler; Birgit Frauscher; Michael Schocke; Michael Nocker; Viola Gschliesser; Laura Ehrmann; Markus Niederreiter; Regina Esterhammer; Klaus Seppi; Elisabeth Brandauer; Werner Poewe; Birgit Högl
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

Review 6.  Unearthing the phylogenetic roots of sleep.

Authors:  Ravi Allada; Jerome M Siegel
Journal:  Curr Biol       Date:  2008-08-05       Impact factor: 10.834

Review 7.  The orexins/hypocretins and schizophrenia.

Authors:  Ariel Y Deutch; Michael Bubser
Journal:  Schizophr Bull       Date:  2007-08-28       Impact factor: 9.306

8.  Metabolism-independent sugar sensing in central orexin neurons.

Authors:  J Antonio González; Lise T Jensen; Lars Fugger; Denis Burdakov
Journal:  Diabetes       Date:  2008-06-30       Impact factor: 9.461

9.  Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy.

Authors:  Rositsa Poryazova; Betina Schnepf; Esther Werth; Ramin Khatami; Ulrike Dydak; Dieter Meier; Peter Boesiger; Claudio L Bassetti
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

10.  Feeding-elicited cataplexy in orexin knockout mice.

Authors:  E L Clark; C R Baumann; G Cano; T E Scammell; T Mochizuki
Journal:  Neuroscience       Date:  2009-04-08       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.